- Home
- UBER vs BMY Comparison
UBER vs BMY Comparison
Compare UBER & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UBER | BMY |
|---|---|---|
| Founded | 2009 | 1887 |
| Country | United States | United States |
| Employees | N/A | 32500 |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.9B | 123.7B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | UBER | BMY |
|---|---|---|
| Price | $77.23 | $60.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 33 | 16 |
| Target Price | ★ $107.03 | $62.13 |
| AVG Volume (30 Days) | ★ 12.3M | 9.2M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.27% |
| EPS Growth | ★ 3.73 | N/A |
| EPS | ★ 4.73 | N/A |
| Revenue | ★ $52,017,000,000.00 | N/A |
| Revenue This Year | $14.40 | N/A |
| Revenue Next Year | $14.27 | N/A |
| P/E Ratio | ★ $16.17 | $17.26 |
| Revenue Growth | ★ 18.28 | N/A |
| 52 Week Low | $68.46 | $42.52 |
| 52 Week High | $101.99 | $62.89 |
Technical Indicators
Market Signals| Indicator | UBER | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 60.40 | 56.14 |
| Support Level | $68.74 | $59.23 |
| Resistance Level | $78.74 | $62.39 |
| Average True Range (ATR) | 2.26 | 1.29 |
| MACD | 0.76 | 0.04 |
| Stochastic Oscillator | 83.50 | 63.54 |
Price Performance
Historical ComparisonAbout UBER Uber Technologies Inc.
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food couriers, and shippers with carriers. The firm's on-demand technology platform is currently utilized by traditional cars as well as autonomous vehicles, but could eventually be used for additional products and services, such as delivery via drones or electronic vehicle take-off and landing (eVTOL) technology. Uber operates in over 70 countries, with over 202 million users who order rides or food at least once a month.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.